Company Filing History:
1 out of 3,923 
1 out of 2 
1 out of 47 Years Active: 2010-2011
Title: Innovations by Johan Holst
Introduction
Johan Holst is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of vaccine development, particularly in combination vaccines aimed at treating or preventing infections. His work has led to the filing of two patents, showcasing his innovative approach to healthcare.
Latest Patents
Holst's latest patents include groundbreaking advancements in combination vaccines. These vaccines incorporate serogroup B proteoliposomic vesicles and serogroup C conjugated oligosaccharides. Additionally, he has cloned, sequenced, and expressed an 85 kDa antigen from Neisseria, which is common to diverse strains, serogroups, and serotypes. The protein sequences of serogroups A and B are highly homologous, indicating a significant overlap in their genetic makeup.
Career Highlights
Throughout his career, Johan Holst has worked with prominent organizations such as Novartis AG and the Norwegian Institute of Public Health. His experience in these institutions has allowed him to contribute to important research and development projects in the field of immunology.
Collaborations
Holst has collaborated with esteemed colleagues, including Dan M Granoff and Howard V Raff. These partnerships have further enriched his research and have led to advancements in vaccine technology.
Conclusion
Johan Holst's contributions to vaccine development and his innovative patents highlight his importance in the field of immunology. His work continues to influence the way we approach infectious diseases and vaccine formulation.